Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ZYMEWORKS INC.

(ZYME)
  Report
Delayed Nyse  -  01:00 2022-11-25 pm EST
7.840 USD   -2.49%
11/22Zymeworks Announces Abstract For Zanidatamab In Late-Line HER2-Positive Hormone-Receptor Positive Metastatic Breast Cancer At The San Antonio Breast Cancer Symposium
AQ
11/22Zymeworks Announces Participation in Upcoming Investor Conference
BU
11/21HC Wainwright Adjusts Price Target on Zymeworks to $10 From $8, Maintains Neutral Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on ZYMEWORKS INC.
11/21HC Wainwright Adjusts Price Target on Zymeworks to $10 From $8, Maintains Neutral Ratin..
MT
11/01HC Wainwright Downgrades Zymeworks to Neutral From Buy, Lowers Price Target to $8 From ..
MT
10/24Stifel Adjusts Zymeworks' Price Target to $18 From $21, Reiterates Buy Rating
MT
10/21SVB Securities Downgrades Zymeworks to Market Perform From Outperform, Adjusts Price Ta..
MT
09/13Citigroup Lowers Zymeworks Price Target to $21 From $27, Maintains Buy Rating
MT
08/29Citigroup Trims Price Target on Zymeworks to $27 From $28, Reiterates Buy Rating
MT
05/27SVB Securities Adjusts Zymeworks' Price Target to $19 from $18, Keeps Outperform Rating
MT
05/23HC Wainwright Adjusts Zymeworks' Price Target to $40 from $44, Keeps Buy Rating
MT
05/09Citigroup Lowers Zymeworks Price Target to $28 From $30, Buy Rating Kept
MT
05/05Guggenheim Upgrades Zymeworks to Buy From Neutral; Price Target is $14
MT
03/15Evercore ISI Starts Zymeworks at Outperform With $15 Price Target
MT
02/25Stifel Adjusts Price Target for Zymeworks to $24 From $51, Maintains Buy Rating
MT
02/09Wells Fargo Adjusts Zymeworks' Price Target to $45 From $56, Reiterates Overweight Rati..
MT
2021Raymond James Downgrades Zymeworks to Outperform From Strong Buy; Price Target is $74
MT
2021SVB Leerink Upgrades Zymeworks to Outperform From Market Perform
MT
2021Guggenheim Assumes Zymeworks at Neutral
MT
2021SVB Leerink Adjusts Zymeworks' Price Target to $28 from $43, Keeps Market Perform Ratin..
MT
2021Zymeworks : Jefferies Starts Zymeworks at Hold with $32 Price Target
MT
2021Zymeworks : HC Wainwright Adjusts Zymeworks' Price Target to $44 From $55, Kee..
MT
2021Zymeworks : HC Wainwright Adjusts Price Target on Zymeworks to $55 From $57, M..
MT
2021Zymeworks : Credit Suisse Starts Zymeworks at Outperform with $55 PT, Notes Pi..
MT
2021Zymeworks : SVB Leerink Downgrades Zymeworks to Market Perform From Outperform..
MT
2021Zymeworks : HC Wainwright Analyst Starts Zymeworks at Buy With $57 Price Targe..
MT
2021Zymeworks : Barclays Adjusts Zymeworks PT to $38 From $47, Maintains Equal Wei..
MT
2021Zymeworks : Citigroup Downgrades Zymeworks to Neutral From Buy, Adjusts Price ..
MT